← Back to all trials
Recruiting
NCT06344338
Application of tDCS Stimulation in Controlling Refractory Status Epilepticus
Conditions: Refractory Status Epilepticus
Sex: All
Ages: 14 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 32
Sponsor: Xuanwu Hospital, Beijing
Location: Xuanwu Hospital, Capital Medical University Beijing Beijing Municipality
Summary
The purpose of the study is to assess the efficacy and safety of targeting tDCS stimulation for treatment of Refractory status epilepticus
Eligibility Criteria
Inclusion Criteria:
* Age between 14 and 80 year-old with Gender unlimited,
* Suitable for EEG monitoring;
* Clinical diagnosis of Refractory status epilepticus (status epilepticus that cannot be controlled by two types of antiepileptic drugs and at least one anesthetic);
* Informed consent to participate in this study was obtained from the participants or their surrogates
Exclusion Criteria:
* Unstable vital signs (systolic blood pressure\
Source: ClinicalTrials.gov (NCT06344338). StuddyBuddy aggregates publicly available trial information.
